First Carolina Financial Services, Inc. reported its financial results for the quarter ended September 30, 2026, highlighting continued growth in net interest income and a stable credit profile. The filing emphasizes the company's strategic focus on community banking and maintaining strong capital ratios amidst evolving economic conditions.
For the three months ended September 30, 2026, MacKenzie Realty Capital reported a net loss attributable to common stockholders of $4.54 million, or $1.64 per share, compared to a loss of $4.09 million in the prior year period. Total assets increased slightly to $236.99 million, while total equity declined to $75.91 million due to an increasing accumulated deficit and dividend distributions.
Smith-Midland Corporation reported total revenue of $22.8 million for the third quarter of 2026, a slight increase from $21.5 million in the prior year, driven by strong barrier rental growth. However, nine-month net income decreased significantly to $5.7 million compared to $10.4 million in 2025, primarily due to higher operating expenses and lower year-to-date barrier rental revenue.
Brookfield Oaktree Holdings, LLC reported a decrease in corporate investments from $1.43 billion at year-end 2025 to $1.23 billion as of September 30, 2026. The company maintained its status as a non-accelerated filer and reported 118,832,320 Class A units outstanding as of November 16, 2026.
PrimeEnergy Resources Corporation is a non-accelerated filer and smaller reporting company with 1,574,500 shares of common stock outstanding as of November 16, 2026. The filing includes condensed consolidated financial statements for the period ending September 30, 2026, and highlights risks related to commodity price volatility and geopolitical instability.
Firy Inc. reported a net loss of $47.9 million for the nine months ended September 30, 2026, an improvement from the $52.5 million loss in the prior year period. Revenue grew to $91.4 million for the nine months, while the company significantly reduced its debt through an $80 million redemption of senior secured notes.
For the nine months ended September 30, 2026, HireQuest reported total revenue of $23.4 million and net income of $5.9 million, an increase from $4.7 million in the prior year period. The company maintained its dividend at $0.06 per share for the quarter while managing a significant increase in accounts receivable and a reduction in cash to $1.1 million.
Aytu BioPharma reported significant warrant reclassifications from liability to equity following amendments in March 2026. The company maintains a $3.8 million Employee Retention Credit accrual and continues to manage debt through an Eclipse Business Capital loan agreement, while focusing on its ADHD and Pediatric portfolios.
The filing provides a Section 13(r) disclosure regarding a minority noncontrolling interest in Malaysia Airports Holdings Berhad held by affiliates of Global Infrastructure Partners. It reports that Iran Airtour resumed flight operations to one of the airports operated by the entity starting in August 2026.
Powell Industries reported record fourth quarter and full-year fiscal 2026 results, with annual revenue reaching $1.3 billion and net income growing 22% to $221 million. The company achieved a record backlog of $2.7 billion, driven by $2.6 billion in new orders during the year, including significant wins in the LNG and data center markets.
Term
FY2026
“Our fourth quarter marked a strong finish to an exceptional year of progress for Powell. We generated $710 million of new orders in the quarter, with the Oil and Gas market making a substantial contribution, bringing total Fiscal 2026 new orders to a record $2.6 billion.”
Brett A. Cope, Powell’s Chairman and Chief Executive Officer
“The quarter included two mega orders, one in the LNG end market and the other in the data center market, each reflecting the scale of our project capabilities and the trust our customers place in our team.”
Brett A. Cope, Powell’s Chairman and Chief Executive Officer
Cantor Equity Partners IV, Inc. reported a net income of $12.17 million for the nine months ended September 30, 2026, primarily driven by $12.65 million in interest income from its Trust Account. As a shell company, it continues to manage its Class A ordinary shares subject to possible redemption, which were valued at $469.09 million as of the period end.
Precision Optics Corporation reported revenues of $8.15 million for the quarter ended September 30, 2026, a 22% increase compared to the prior year. Despite the revenue growth and a significantly improved gross profit of $1.84 million, the company recorded a net loss of $474,854, which was a substantial reduction from the $1.64 million loss in the same period of 2025.
Cantor Equity Partners I, Inc. reported a significant net income of $32.8 million for the nine months ended September 30, 2026, primarily driven by a $15 million business combination termination fee and a $13.2 million gain from the change in fair value of forward sale securities. As a shell company, it continues to seek a business combination while maintaining $213.1 million in its Trust Account.
For the nine months ended September 30, 2026, Cantor Equity Partners V, Inc. reported net income of $6.55 million, primarily driven by $7.03 million in interest income from its Trust Account. The company remains a shell company with $258.4 million in Class A ordinary shares subject to possible redemption and is actively seeking a business combination.
Connect Biopharma reported a net loss of $52.8 million for the nine months ended September 30, 2026, compared to $40.4 million in the prior year, primarily driven by a significant increase in research and development expenses. Total assets decreased from $56.1 million at year-end 2025 to $27.8 million as of September 30, 2026, reflecting the company's continued cash burn for clinical operations.
Cantor Equity Partners VI, Inc. reported a net income of $2.25 million for the nine months ended September 30, 2026, primarily driven by $2.70 million in interest income from its Trust Account. The company completed its initial public offering in early 2026, resulting in $117.70 million held in trust and 11.5 million Class A ordinary shares subject to possible redemption.
InspireMD reported a net loss of $37.8 million for the nine months ended September 30, 2026, compared to $37.0 million in the prior year period. While revenues grew to $7.4 million from $5.8 million year-over-year, the company experienced a significant decrease in cash and marketable securities, ending the period with $19.2 million in cash.
D. Boral Acquisition I Corp. reported a net income of $6,007,828 for the nine months ended September 30, 2026, primarily driven by $6,765,686 in interest income from its Trust Account. As a shell company, its activities were focused on its Initial Public Offering and the subsequent search for a target business, with $294,265,686 currently held in trust.
Treasure Global Inc. reported a significant revenue increase to $2.21 million for the quarter ended September 30, 2026, compared to $0.18 million in the prior year, though it recorded a slight gross loss. The company achieved a net income of $1.79 million, primarily driven by a $2.96 million gain from the change in fair value of derivative assets and liabilities.
Data443 Risk Mitigation reported a net loss of $2,397,079 for the nine months ended September 30, 2026, compared to a loss of $1,597,069 in the prior year period. Revenue decreased to $2,714,956 from $3,497,748, while the company's stockholders' deficit widened to $16,480,567.
Hepion Pharmaceuticals reported a net loss of $6.6 million for the nine months ended September 30, 2026, compared to a $7.6 million loss in the prior year period. The company's financial position shows a stockholders' deficit of $4.0 million, and management highlighted significant uncertainties regarding their ability to raise additional capital to continue as a going concern.
Cantor Equity Partners VII, Inc. completed its initial public offering in 2026, raising $250 million and placing $252.5 million into a Trust Account. For the nine months ended September 30, 2026, the company reported net income of $2,313,959, primarily driven by $2,560,158 in interest income on investments held in the Trust Account.
GameSquare Holdings reported a significant revenue increase to $52.0 million for the nine months ended September 30, 2026, compared to $26.0 million in the prior year period. Despite this growth, the company realized a net loss of $18.3 million, driven by higher operating expenses and a substantial realized loss on digital assets and ETH fund investments.
Oncotelic Therapeutics reported a net loss of $2.92 million for the nine months ended September 30, 2026, compared to a loss of $1.07 million in the prior year period. The company's balance sheet is dominated by a $388 million investment in GMP Bio at fair value, while it continues to manage significant debt obligations and a working capital deficit.
Safe Pro Group Inc. reported a significant revenue increase to $5.23 million for the nine months ended September 30, 2026, compared to $0.38 million in the prior year. Despite this growth, the company recorded a net loss of $7.51 million, driven by high operating expenses including $5.65 million in salaries and $2.34 million in professional fees.
Seafarer Exploration Corp. reported a net loss of $2,367,325 for the nine months ended September 30, 2026, compared to a loss of $2,055,690 in the prior year period. The company remains in a development stage with zero revenue and a total stockholders' deficit of $3,632,689 as of the reporting date.
Roadzen Inc. reported a revenue increase to $33.8 million for the six months ended September 30, 2026, compared to $24.5 million in the prior year. However, the company experienced a net loss of $13.9 million for the period, driven by increased interest expenses and fair value losses on financial instruments. The company remains in a total shareholders' deficit of $36.5 million as of September 30, 2026.
D-Wave Quantum Inc. reported a net loss of $48.2 million for the third quarter of 2026, an improvement from the $140.0 million loss in the prior year period, primarily due to the absence of warrant liability fair value changes. While quarterly revenue grew to $4.5 million, year-to-date revenue declined significantly to $10.4 million compared to $21.8 million in 2025, alongside a substantial increase in research and development expenses.
PetVivo Holdings reported a net loss of $3,560,419 for the six months ended September 30, 2026, compared to $4,555,587 in the prior year period. Revenues decreased slightly to $550,377, while the company experienced a significant reduction in cash to $16,287 and a total stockholders' deficit of $159,093.
Starfighters Space, Inc. reported a net loss of $20.3 million for the nine months ended September 30, 2026, significantly higher than the $7.0 million loss in the prior year period, driven by a $5.15 million impairment of aircraft deposits and increased SG&A expenses. The company raised $17.5 million through PIPE financing but faces substantial doubt about its ability to continue as a going concern due to historical losses and restricted bank accounts from ongoing litigation.